{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T04:29:39Z","timestamp":1782016179073,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K15297"],"award-info":[{"award-number":["JP22K15297"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bcp.2025.116792","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T18:11:27Z","timestamp":1738347087000},"page":"116792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Simvastatin and rosuvastatin attenuate necroptosis in rat failing hearts following myocardial infarction; the contribution of Hsp90 inhibition in cardiomyocytes to prevent necroptosis"],"prefix":"10.1016","volume":"233","author":[{"given":"Tetsuro","family":"Marunouchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasumi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaho","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-790X","authenticated-orcid":false,"given":"Kouichi","family":"Tanonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.116792_b0005","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.csbj.2020.04.004","article-title":"Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs","volume":"18","author":"Parisi","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"10.1016\/j.bcp.2025.116792_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jphs.2022.11.002","article-title":"Simvastatin attenuates the c-Raf\/Erk and calcineurin-NFATc2 pathways via inhibition of Hsp90 activity during the development of heart failure","volume":"151","author":"Marunouchi","year":"2023","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.116792_b0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.bcp.2025.116792_b0020","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2005.05.086","article-title":"The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes","volume":"46","author":"Ray","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2025.116792_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173987","article-title":"Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice","volume":"898","author":"Marunouchi","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2025.116792_b0030","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/FJC.0000000000001017","article-title":"Hsp90 inhibitor attenuates the development of pathophysiological cardiac fibrosis in mouse hypertrophy via suppression of the calcineurin-NFAT and c-Raf-Erk pathways","volume":"77","author":"Marunouchi","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116792_b0035","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jphs.2021.06.009","article-title":"Effects of 17-AAG on the RIP1\/RIP3\/MLKL pathway during the development of heart failure following myocardial infarction in rats","volume":"147","author":"Marunouchi","year":"2021","journal-title":"J. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2025.116792_b0040","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1254\/jphs.13109FP","article-title":"Possible involvement of HSP90-HSF1 multichaperone complex in impairment of HSP72 induction in the failing heart following myocardial infarction in rats","volume":"123","author":"Marunouchi","year":"2013","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.116792_b0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000534933","article-title":"Simvastatin attenuates cardiac fibrosis under pathophysiological conditions of heart failure with preserved left ventricular ejection fraction by inhibiting TGF-beta signaling","volume":"109","author":"Marunouchi","year":"2024","journal-title":"Pharmacology"},{"issue":"4","key":"10.1016\/j.bcp.2025.116792_b0050","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1248\/bpb.b23-00741","article-title":"Angiotensin II Is involved in MLKL activation during the development of heart failure following myocardial infarction in rats","volume":"47","author":"Marunouchi","year":"2024","journal-title":"Biol. Pharm. Bull."},{"issue":"7534","key":"10.1016\/j.bcp.2025.116792_b0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.bcp.2025.116792_b0060","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.1074\/jbc.275.14.10519","article-title":"Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation","volume":"275","author":"Lewis","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2025.116792_b0065","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1074\/jbc.M208925200","article-title":"Disruption of HSP90 function reverts tumor necrosis factor-induced necrosis to apoptosis","volume":"278","author":"Vanden Berghe","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.116792_b0070","doi-asserted-by":"crossref","first-page":"e2051","DOI":"10.1038\/cddis.2015.386","article-title":"HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death","volume":"7","author":"Jacobsen","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.116792_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115547","article-title":"Involvement of Hsp90 in NLRP3 inflammasome activation in the failing heart following myocardial infarction in rats","volume":"212","author":"Marunouchi","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116792_b0080","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12944-019-1135-z","article-title":"Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis","volume":"18","author":"Bielecka-Dabrowa","year":"2019","journal-title":"Lipids Health Dis."},{"issue":"6","key":"10.1016\/j.bcp.2025.116792_b0085","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/1755-5922.12150","article-title":"Effects of statin treatment on inflammation and cardiac function in heart failure: an adjusted indirect comparison meta-analysis of randomized trials","volume":"33","author":"Bonsu","year":"2015","journal-title":"Cardiovasc. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2025.116792_b0090","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.amjcard.2004.10.039","article-title":"Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent percutaneous coronary intervention for acute myocardial infarction","volume":"95","author":"Hong","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116792_b0095","first-page":"30","article-title":"A review of the role of statins in heart failure treatment","volume":"15","author":"Niazi","year":"2020","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2025.116792_b0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2022.05.006","article-title":"Necroptosis in heart disease: Molecular mechanisms and therapeutic implications","volume":"169","author":"Guo","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116792_b0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","article-title":"Necroptosis: the release of damage-associated molecular patterns and its physiological relevance","volume":"38","author":"Kaczmarek","year":"2013","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.bcp.2025.116792_b0110","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1161\/CIRCRESAHA.110.225730","article-title":"Programmed necrosis, not apoptosis, in the heart","volume":"108","author":"Kung","year":"2011","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.116792_b0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","article-title":"Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways","volume":"60","author":"Koushki","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116792_b0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pharmthera.2009.01.002","article-title":"Statins and cardioprotection\u2013more than just lipid lowering?","volume":"122","author":"Ludman","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.116792_b0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2007.07.036","article-title":"Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches","volume":"131","author":"McClellan","year":"2007","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bcp.2025.116792_b0130","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/PL00012491","article-title":"Heat-shock protein 90, a chaperone for folding and regulation","volume":"59","author":"Picard","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.bcp.2025.116792_b0135","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1111\/cas.13748","article-title":"Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer","volume":"109","author":"Kou","year":"2018","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.bcp.2025.116792_b0140","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1124\/dmd.108.021410","article-title":"Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin","volume":"36","author":"Kitamura","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2025.116792_b0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2025.116792_b0150","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1124\/dmd.114.058412","article-title":"Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data","volume":"42","author":"Kunze","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2025.116792_b0155","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/ATVBAHA.119.313832","article-title":"Statins disrupt macrophage Rac1 regulation leading to increased atherosclerotic plaque calcification","volume":"40","author":"Healy","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.bcp.2025.116792_b0160","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1161\/ATVBAHA.118.311664","article-title":"Myeloid HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase determines atherosclerosis by modulating migration of macrophages","volume":"38","author":"Sakai","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2025.116792_b0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vph.2018.08.003","article-title":"Statin treatment reduces matrix degradation capacity of proinflammatory polarized macrophages","volume":"110","author":"Hohensinner","year":"2018","journal-title":"Vascul. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.116792_b0170","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/ATVBAHA.107.160663","article-title":"Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3\/IFN-beta pathway in macrophages","volume":"28","author":"Abe","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116792_b0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41419-021-03389-1","article-title":"Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.116792_b0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10557-013-6498-1","article-title":"Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model","volume":"28","author":"Luo","year":"2014","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"11","key":"10.1016\/j.bcp.2025.116792_b0185","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: JACC state-of-the-art review","volume":"75","author":"Murphy","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.bcp.2025.116792_b0190","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13453","article-title":"Chronic low-grade inflammation in heart failure with preserved ejection fraction","volume":"20","author":"Mesquita","year":"2021","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.bcp.2025.116792_b0195","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1253\/circj.CJ-18-0639","article-title":"Effect of statins on mortality in heart failure with preserved ejection fraction without coronary artery disease- Report from the JASPER study","volume":"83","author":"Marume","year":"2019","journal-title":"Circ. J."},{"issue":"5","key":"10.1016\/j.bcp.2025.116792_b0200","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/CIRCHEARTFAILURE.115.002143","article-title":"Association between use of statins and mortality in patients with heart failure and ejection fraction of >\/=50","volume":"8","author":"Alehagen","year":"2015","journal-title":"Circ. Heart Fail."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225000541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225000541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T12:13:39Z","timestamp":1745842419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225000541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":40,"alternative-id":["S0006295225000541"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116792","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simvastatin and rosuvastatin attenuate necroptosis in rat failing hearts following myocardial infarction; the contribution of Hsp90 inhibition in cardiomyocytes to prevent necroptosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116792"}}